Mostrando 3 resultados de: 3
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies
ArticleAbstract: Background: There are an abundance of commercially available lateral flow assays (LFAs) that detectPalabras claves:covid-19, IGG, Igm, Lateral flow immunoassays, SARS-COV-2Autores:Adams E.R., Baldwin L., Brown L., Byrne R.L., Collins A.M., Cubas-Atienzar A.I., Cuevas L.E., de Vos M., Edwards T., Escadafal C., Ferreira D.M., Fletcher T.E., Fraser A.J., Garrod G., Hyder-Wright A., Kay G.A., Kontogianni K., Mason J., Mitsi E., Owen S.I., Planche T., Sacks J.A., Stefanie K. Menzies, Taylor J., Todd S., Tully C., Williams C.T.Fuentes:scopusSaliva alternative to upper respiratory swabs for SARS-CoV-2 diagnosis
ArticleAbstract: PCR of upper respiratory specimens is the diagnostic standard for severe acute respiratory syndromePalabras claves:Autores:Adams E.R., Aljayyoussi G., Brown L., Byrne R.L., Collins A.M., Cubas-Atienzar A.I., Cuevas L.E., Ferreira D.M., Fletcher T.E., Fraser A.J., Garrod G., Hill H., Hughes G.L., Hyder-Wright A., Kay G.A., Kontogianni K., Mitsi E., Owen S.I., Patterson E.I., Stefanie K. Menzies, Todd S., Williams C.T.Fuentes:scopusSelf-sampling of capillary blood for SARS-CoV-2 serology
ArticleAbstract: Serological testing is emerging as a powerful tool to progress our understanding of COVID-19 exposurPalabras claves:Autores:Adams E.R., Brown L., Byrne R.L., Cubas-Atienzar A.I., Cuevas L.E., Fitchett J.R.A., Fletcher T.E., Fraser A.J., Garrod G., Kay G.A., Kontogianni K., Krishna S., Owen S.I., Planche T., Sainter C., Staines H.M., Stefanie K. Menzies, Turtle L., Williams C.T.Fuentes:scopus